An emerging phenomenon – FGF21 resistance in obesity, due to diminished sensitivity of its coreceptor β‐klotho, raises concern on the rewiring energy balance in dual MASLD‐obesity burden. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.